{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:12:34Z","timestamp":1790907154499,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Halle (Saale)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Clinical background<\/jats:title>\n                    <jats:p>Cancer registry data are an essential resource for population-based oncology research and quality assurance in Germany. With the revision of the Federal Cancer Registry Data Act in 2021, for the first time, a\u00a0legal basis was created for the development of a\u00a0nationwide clinical cancer dataset. This registry offers new opportunities for research, particularly in radiation oncology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aims to provide an overview of the current possibilities of and challenges to using German cancer registry data in radiation oncology, with a\u00a0focus on data structure, missing data, access procedures, and methodological aspects for scientific research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined legal frameworks, data access procedures, and the structure of the nationwide basic oncology dataset (oBDS), particularly the components relevant to radiotherapy (RT). The completeness and comprehensiveness of RT data across federal states were assessed using national registry data from the German Center for Cancer Registry Data (ZfKD) for the years 2020\u20132022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cancer registries provide structured data on RT through the oBDS, including treatment intent, technique, target area, and side effects. However, significant variability in terms of completeness and reporting standards persists among federal states. Missing data rates remain high in some regions, particularly for key RT parameters such as treatment technique, the relationship to surgery, and boost application. Methodological challenges for scientific use include handling missing data, confounding, immortal time bias, and exposure misclassification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite existing limitations, cancer registry data in Germany represent a\u00a0valuable resource for real-world research in radiation oncology. They allow for large-scale population-based studies beyond the constraints of clinical trials. With improved data harmonization, methodological rigor, and future data linkages (e.g., to health insurance data), registry-based studies can contribute significantly to evidence-based decision-making and quality improvement in radiation oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-025-02486-w","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:21:59Z","timestamp":1762788119000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Research with cancer registry data in radiation oncology\u2014current possibilities and perspectives"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0843-7373","authenticated-orcid":false,"given":"J\u00f6rg Andreas","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Oesterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Graw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kluttig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Medenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"5","key":"2486_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00103-004-0827-2","volume":"47","author":"A Katalinic","year":"2004","unstructured":"Katalinic\u00a0A (2004) Bestandsaufnahme und Perspektiven (population-based cancer registration in Germany. Essentials and perspectives). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47(5):422\u2013428. https:\/\/doi.org\/10.1007\/s00103-004-0827-2","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"6","key":"2486_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.zefq.2015.08.001","volume":"109","author":"M Klinkhammer-Schalke","year":"2015","unstructured":"Klinkhammer-Schalke\u00a0M, Gerken\u00a0M, Barlag\u00a0H et\u00a0al (2015) Was k\u00f6nnen Klinische Krebsregister in Zukunft f\u00fcr die bev\u00f6lkerungsbezogene Umsetzung evidenzbasierter Leitlinien leisten? (quality management in oncology supported by clinical cancer registries). Z\u00a0Evid Fortbild Qual Gesundhwes 109(6):452\u2013458. https:\/\/doi.org\/10.1016\/j.zefq.2015.08.001","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"issue":"4","key":"2486_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00761-023-01426-6","volume":"30","author":"A Katalinic","year":"2024","unstructured":"Katalinic\u00a0A, Pritzkuleit\u00a0R, Kraywinkel\u00a0K (2024) Forschung mit Krebsregistern \u2013 was geht, was (noch) nicht? Onkologie 30(4):280\u2013288. https:\/\/doi.org\/10.1007\/s00761-023-01426-6","journal-title":"Onkologie"},{"issue":"2","key":"2486_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00761-010-1941-4","volume":"17","author":"D H\u00f6lzel","year":"2011","unstructured":"H\u00f6lzel\u00a0D (2011) Versorgungsforschung mit Krebsregistern. Onkologe 17(2):143\u2013152. https:\/\/doi.org\/10.1007\/s00761-010-1941-4","journal-title":"Onkologe"},{"issue":"2","key":"2486_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00404-019-05387-3","volume":"301","author":"C Taubenhansl","year":"2020","unstructured":"Taubenhansl\u00a0C, Ortmann\u00a0O, Gerken\u00a0M et\u00a0al (2020) Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients. Arch Gynecol Obstet 301(2):573\u2013583. https:\/\/doi.org\/10.1007\/s00404-019-05387-3","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2486_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ygyno.2020.03.016","volume":"157","author":"J Dholakia","year":"2020","unstructured":"Dholakia\u00a0J, Llamocca\u00a0E, Quick\u00a0A et\u00a0al (2020) Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer. Gynecol Oncol 157(3):716\u2013722. https:\/\/doi.org\/10.1016\/j.ygyno.2020.03.016","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2486_CR7","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1007\/s00432-022-04318-1","volume":"149","author":"S Scharl","year":"2023","unstructured":"Scharl\u00a0S, Spr\u00f6tge\u00a0T, Gerken\u00a0M et\u00a0al (2023) Guideline concordant therapy improves survival in high-grade endometrial cancer patients. J\u00a0Cancer Res Clin Oncol 149(8):4761\u20134769. https:\/\/doi.org\/10.1007\/s00432-022-04318-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"2486_CR8","unstructured":"Bundesministerium f\u00fcr gesundheit Bundeskrebsregisterdatengesetz (BKRG). https:\/\/www.bundesgesundheitsministerium.de\/service\/begriffe-von-a-z\/b\/bundeskrebsregisterdatengesetz.html. Accessed 26 Jan 2025"},{"issue":"5","key":"2486_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00432-021-03537-2","volume":"147","author":"A Bedir","year":"2021","unstructured":"Bedir\u00a0A, Abera\u00a0SF, Efremov\u00a0L et\u00a0al (2021) Socioeconomic disparities in head and neck cancer survival in Germany: a\u00a0causal mediation analysis using population-based cancer registry data. J\u00a0Cancer Res Clin Oncol 147(5):1325\u20131334. https:\/\/doi.org\/10.1007\/s00432-021-03537-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"17","key":"2486_CR10","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.1007\/s00432-023-05289-7","volume":"149","author":"A Bedir","year":"2023","unstructured":"Bedir\u00a0A, Mehrotra\u00a0S, Gn\u00fcchtel\u00a0J et\u00a0al (2023) Treatment patterns in stage\u00a0III non-small-cell lung cancer patients: a\u00a0population-based study using German cancer registry data. J\u00a0Cancer Res Clin Oncol 149(17):15489\u201315497. https:\/\/doi.org\/10.1007\/s00432-023-05289-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"2486_CR11","volume-title":"Krebs in Deutschland f\u00fcr 2019\/2020","author":"Koch-Institut, Robert","year":"2023","unstructured":"Koch-Institut, Robert (2023) Krebs in Deutschland f\u00fcr 2019\/2020. Robert Koch-Institut"},{"issue":"12","key":"2486_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00066-018-1357-4","volume":"194","author":"D Medenwald","year":"2018","unstructured":"Medenwald\u00a0D, Dietzel\u00a0CT, Vordermark\u00a0D (2018) Medizinische Versorgungsforschung in der Radioonkologie: neue Optionen f\u00fcr Fortschritte in der Krebsbehandlung (health services research in German radiation oncology: new opportunities to advance cancer care). Strahlentherapie Onkol : Organ Dtsch Rontgengesellschaft \u2026 [et Al] 194(12):1097\u20131102. https:\/\/doi.org\/10.1007\/s00066-018-1357-4","journal-title":"Strahlentherapie Onkol : Organ Dtsch Rontgengesellschaft \u2026 [et Al]"},{"issue":"1","key":"2486_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.radonc.2015.02.024","volume":"115","author":"B Hager","year":"2015","unstructured":"Hager\u00a0B, Kraywinkel\u00a0K, Keck\u00a0B et\u00a0al (2015) Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: a\u00a0comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol 115(1):90\u201395. https:\/\/doi.org\/10.1016\/j.radonc.2015.02.024","journal-title":"Radiother Oncol"},{"key":"2486_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123814","author":"D Medenwald","year":"2020","unstructured":"Medenwald\u00a0D, Langer\u00a0S, Gottschick\u00a0C et\u00a0al (2020) Effect of radiotherapy in addition to surgery in early stage Endometrial cancer: a\u00a0population-based study. Cancers. https:\/\/doi.org\/10.3390\/cancers12123814","journal-title":"Cancers"},{"key":"2486_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082334","author":"P Rogowski","year":"2023","unstructured":"Rogowski\u00a0P, Sch\u00f6necker\u00a0S, Konnerth\u00a0D et\u00a0al (2023) Adjuvant therapy for elderly breast cancer patients after breast-conserving surgery: outcomes in real world practice. Cancers. https:\/\/doi.org\/10.3390\/cancers15082334","journal-title":"Cancers"},{"issue":"9","key":"2486_CR16","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1093\/oncolo\/oyac114","volume":"27","author":"L Azoulay","year":"2022","unstructured":"Azoulay\u00a0L (2022) Rationale, strengths, and limitations of real-world evidence in oncology: a\u00a0Canadian review and perspective. The Oncol 27(9):e731\u2013e738. https:\/\/doi.org\/10.1093\/oncolo\/oyac114","journal-title":"The Oncol"},{"issue":"1","key":"2486_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12874-023-01937-1","volume":"23","author":"F Liu","year":"2023","unstructured":"Liu\u00a0F, Panagiotakos\u00a0D (2023) Correction: real-world data: a\u00a0brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol 23(1):109. https:\/\/doi.org\/10.1186\/s12874-023-01937-1","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2486_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00432-021-03908-9","volume":"148","author":"A Bedir","year":"2022","unstructured":"Bedir\u00a0A, Abera\u00a0SF, Vordermark\u00a0D et\u00a0al (2022) Socioeconomic disparities in endometrial cancer survival in Germany: a\u00a0survival analysis using population-based cancer registry data. J\u00a0Cancer Res Clin Oncol 148(5):1087\u20131095. https:\/\/doi.org\/10.1007\/s00432-021-03908-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"2486_CR19","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00432-021-03596-5","volume":"147","author":"L Efremov","year":"2021","unstructured":"Efremov\u00a0L, Abera\u00a0SF, Bedir\u00a0A et\u00a0al (2021) Patterns of glioblastoma treatment and survival over a\u00a016-years period: pooled data from the German cancer registries. J\u00a0Cancer Res Clin Oncol 147(11):3381\u20133390. https:\/\/doi.org\/10.1007\/s00432-021-03596-5","journal-title":"J Cancer Res Clin Oncol"},{"issue":"39","key":"2486_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3238\/arztebl.m2023.0184","volume":"120","author":"A Stang","year":"2023","unstructured":"Stang\u00a0A (2023) Evaluability of the effect of oncology center certification. Dtsch \u00c4rztebl Int 120(39):645\u2013646. https:\/\/doi.org\/10.3238\/arztebl.m2023.0184","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"8","key":"2486_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n\u00a0MA, Robins\u00a0JM (2016) Using big data to emulate a\u00a0target trial when a\u00a0randomized trial is not available. Epidemiol Rev 183(8):758\u2013764. https:\/\/doi.org\/10.1093\/aje\/kwv254","journal-title":"Epidemiol Rev"},{"key":"2486_CR22","doi-asserted-by":"publisher","unstructured":"Bedir A, Hassan L, Wittenberg I et\u00a0al (2024) Stereotactic ablative radiotherapy versus video-assisted Lobectomy for operable stage\u00a0I non-small-cell lung cancer: study protocol for an emulated target trial. https:\/\/doi.org\/10.21203\/rs.3.rs-4268816\/v1","DOI":"10.21203\/rs.3.rs-4268816\/v1"},{"issue":"2","key":"2486_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1245\/s10434-007-9658-3","volume":"15","author":"H Nathan","year":"2008","unstructured":"Nathan\u00a0H, Pawlik\u00a0TM (2008) Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 15(2):415\u2013423. https:\/\/doi.org\/10.1245\/s10434-007-9658-3","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"2486_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/gerona\/gly224","volume":"74","author":"CA Presley","year":"2019","unstructured":"Presley\u00a0CA, Chipman\u00a0J, Min\u00a0JY et\u00a0al (2019) Evaluation of frailty as an unmeasured confounder in observational studies of Antidiabetic medications. Journals Gerontol Ser A Biol Sci Med Sci 74(8):1282\u20131288. https:\/\/doi.org\/10.1093\/gerona\/gly224","journal-title":"Journals Gerontol Ser A Biol Sci Med Sci"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02486-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02486-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02486-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:18:42Z","timestamp":1768915122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02486-w"}},"subtitle":["A\u00a0narrative review"],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02486-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.A.\u00a0M\u00fcller, A.\u00a0Bedir, A.\u00a0Katalinic, F.\u00a0Oesterling, A.\u00a0Graw, A.\u00a0Kluttig, S.\u00a0Corradini, D.\u00a0Vordermark, and D.\u00a0Medenwald declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for this study, as it is a\u00a0narrative review and did not involve human participants or identifiable personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}